Relation of Plasma Coagulation Factor VII and Fibrinogen to Carotid Artery Intima-Media Thickness

Summary

Plasma clotting factor VII and plasma fibrinogen have been claimed as independent risk factors for occlusive cardiovascular disease. The aim of this study was to investigate whether these coagulation parameters affect early atherosclerosis, additional to their possible effect on arterial thrombosis.

We used high-resolution quantitative ultrasonography to measure carotid intima-media thickness in 121 healthy volunteers, aged 18 to 56 years. It has previously been demonstrated that an increased artery wall thickness is seen in advanced atherosclerosis. To validate our methodology for relatively young individuals, we assessed the association of intima-media thickness with the risk-factor status of our subjects, by including classical cardiovascular risk factors, e. g. age, sex, serum cholesterol, smoking habits and blood pressure. Thereafter, we studied the effect of factor VII and fibrinogen plasma levels on carotid intimamedia thickness, as well as that of polymorphisms of the factor VII and fibrinogen genes.

All classical risk factors except smoking and family history were associated with intima-media thickness. When adjusted for by multivariate linear regression analysis, age, blood pressure and cholesterol appeared to be independent determinants of intima-media thickness. Factor VII and fibrinogen levels showed no association in multivariate analysis with intima-media thickness. We conclude that artery wall thickness measurement by ultrasound is a useful tool to investigate the role of clotting factors in early atherosclerosis. Factor VII and fibrinogen levels in young and middle-aged volunteers have no association with early artherosclerotic vessel wall changes.

• References

• 1 Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
• 2 Kannel WB, D’Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. kAm Heart J 1987; 113: 1006-1010
• 3 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-537
• 4 Balleisen L, Schulte H, Assman G, Epping PH, Loo Jvan de. Coagulation factors and the progress of coronary heart disease. Lancet 1987; ii: 461
• 5 Ross R. The pathogenesis of atherosclerosis -an update. N Engl J Med 1986; 314: 488-500
• 6 Pignoli P. Ultrasonic evaluation of arterial intima and media thickness. Development and validation of methodology. In: Pathobiology of the human atherosclerotic plaque Glagov S, Newmann WP, Schaffer SA. (ed) Springer Verlag; New York: 1990: 705-732
• 7 Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hyper-cholesterolemic patients. Atheroscler 1988; 70: 253-261
• 8 Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population based ultrasonography study. Atheroscler 1990; 81: 33-40
• 9 Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406
• 10 Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promotor region of the (3 fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991; 65: 487-490
• 11 Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-546
• 12 Koning G, Reiber JHC, Land CDvon, Loois G, Meurs Bvan. Advantages and limitations of two software calipers in quantitative coronary arteriography. Int J Card Imaging 1991; 7: 15-30
• 13 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237
• 14 Owren PA. A quantitative one-stage method for the assay of prothrombin. Scan J Clin Lab Invest 1949; 1: 81
• 15 Hopkins PN, Williams RR. Identification and relative weight of cardiovascular risk factors. Cardiol Clin 1986; 4: 3-31
• 16 Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188-1192
• 17 Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, Yoneda S, Kimura K, Kamada T. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990; 21: 1567-1572
• 18 Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the (α-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb 1993; 13: 886-891
• 19 Koster T, Rosendaal FR, Reitsma PH, Velden PAvan der, Briët E, Van-denbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis: A case-control study of plasma levels and DNA polymorphisms - The Leiden Thrombophilia Study (LETS). Thromb Haemost 1994; 71: 719-722
• 20 Sutton KC, Wolfson SK, Kuller LH. Carotid and lower extremity arterial disease in elderly adults with isolated systolic hypertension. Stroke 1987; 18: 817-822